| 1. | buyermode474 | |
| 2. | RobinFromTheHood | |
| 3. | ColoradoColo |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | buyermode474 01/19/2018 Phase Ib2 data announced |
| 2. | buyermode474 02/12/2018 Announces FDA has granted Orphan Drug Designation to its ABO-202 program |
| 3. | RobinFromTheHood 09/25/2017 Positive upward movement |
| 4. | RobinFromTheHood 09/25/2017 Way Undervalued Has very low expenses EPS=$10, SP=$100+. That is nearly $17 per share in sales along with Europe Based on $25 per share in sales along with Europe. FDA approval=$1.8B |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
AVEO Pharmaceuticals, Inc.
- AVEO
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.